Feeds:
Posts
Comments

Posts Tagged ‘Cougar Biotechnology Inc’

JULY 12: ASSOCIATED PRESS: Johnson & Johnson says it has completed its $US893.7 million acquisition of Cougar Biotechnology Inc, a development stage company that is testing a potential vaccine for prostate cancer. Los Angeles-based Cougar is conducting two late stage clinical trials of abiraterone acetate as a treatment for prostate cancer. READ MORE>

Read Full Post »

MAY 14: FORBES: A US drug development company in the final stage of trialling a drug for prostate cancer patients who have failed chemotherapy has reported a loss of $23.3 million and no revenue. Los Angeles-based Cougar Biotechnology Inc  is also conducting a late-stage study of the drug for prostate cancer patients who have not yet had chemotherapy. READ MORE>

Read Full Post »